Acceptability and Feasibility of Reframe-IT+U for Suicidality in University Students.
Launched by UNIVERSIDAD DE LOS ANDES, CHILE · May 23, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new program called Reframe-IT+U, which aims to help university students who are experiencing thoughts of suicide, depression, or anxiety. The goal is to see if this program, based on a type of therapy called Cognitive Behavioral Therapy (CBT), is acceptable and feasible for students at the Universidad de los Andes. The researchers plan to work with about 20 students who have mild to moderate suicidal risk, providing them with six weekly sessions focused on skills like emotional regulation and problem-solving. They will assess how well the program works and how satisfied participants are with it.
To be eligible for the trial, participants need to be at least 18 years old, undergraduate students at the university, and able to read and speak Spanish. They should have experienced mild to moderate suicidal thoughts in the past month. However, those with severe suicidal risks or untreated serious mental health conditions will not be included. Participants can expect an initial interview, the development of a safety plan, and engaging in both in-person and digital therapy sessions with trained psychologists. The study hopes that this program will not only be feasible for university settings but also help reduce suicidal thoughts among students, paving the way for more extensive research in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 or older.
- • Undergraduate students at Universidad de los Andes.
- • Able to read and speak Spanish.
- • Mild to moderate suicide risk in the past month, defined as having answered "Yes" to items 1, 2, 3, and/or 4 on the Columbia Suicide Severity Rating Scale (C-SSRS).
- Exclusion Criteria:
- • Severe suicide risk, defined as having answered "Yes" to item 5 (past month) or item 6 (past 3 months) on the Columbia Suicide Severity Rating Scale (C-SSRS).
- • Presence of a severe, untreated psychiatric condition during the past year or history of psychiatric hospitalization in the last two years.
- • Determination by the University Wellness Team that the participant is not in a suitable condition to participate due to a severe psychiatric condition or need for hospitalization.
- • High severity of psychotic symptoms (score equal to or greater than 2 on any of items 13, 14, and/or 15 of the Community Assessment of Psychic Experiences - Positive Scale (CAPE, P15)).
About Universidad De Los Andes, Chile
Universidad de los Andes in Chile is a prestigious academic institution renowned for its commitment to advancing research and innovation in the healthcare sector. As a clinical trial sponsor, the university leverages its robust multidisciplinary expertise and state-of-the-art facilities to facilitate cutting-edge medical research. The institution focuses on enhancing patient care and outcomes through rigorous clinical studies, fostering collaboration among healthcare professionals, researchers, and industry partners. With a strong emphasis on ethical standards and regulatory compliance, Universidad de los Andes strives to contribute significantly to the global medical community and improve health solutions in Chile and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported